Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study

[1]  S. Brophy,et al.  Interventions for latent autoimmune diabetes (LADA) in adults. , 2011, The Cochrane database of systematic reviews.

[2]  C. Dubé.  Concordance: A Partnership In Medicine-Taking , 2010 .

[3]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.

[4]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[5]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[6]  D. Spence.  The treatment paradox , 2008, BMJ : British Medical Journal.

[7]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[8]  J. Mehta,et al.  Use of statins in the elderly , 2007 .

[9]  J. Penston,et al.  Patients' preferences shed light on the murky world of guideline-based medicine. , 2007, Journal of evaluation in clinical practice.

[10]  W. Elliott.  Hypertension: Management of hypertension in adults in primary care: partial updateNational Institute for Health and Clinical Excellence ([British] National Collaborating Centre for Chronic Conditions, England; British Hypertension Society, England; Newcastle Guideline Development and Research Unit, , 2007 .

[11]  M Alan Brookhart,et al.  Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.

[12]  P. Gill,et al.  The myth of agency and patient choice in health care? The case of drug treatments to prevent coronary disease. , 2006, Social science & medicine.

[13]  A. Akkad,et al.  Why do women consent to surgery, even when they do not want to? An interactionist and Bourdieusian analysis. , 2006, Social science & medicine.

[14]  P. Gill,et al.  Predictors of patients’ preferences for treatments to prevent heart disease , 2006, Heart.

[15]  M. Kornitzer,et al.  Increased absenteeism from work among aware and treated hypertensive and hypercholesterolaemic patients , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[16]  Diabetes Uk,et al.  JBS 2: Joint British Societies9 guidelines on prevention of cardiovascular disease in clinical practice , 2005 .

[17]  J. Gibbs,et al.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice , 2005, Heart.

[18]  Catherine Pope,et al.  Resisting medicines: a synthesis of qualitative studies of medicine taking. , 2005, Social science & medicine.

[19]  S. Bryan,et al.  Factors influencing clinicians’ decisions to prescribe medication to prevent coronary heart disease , 2005, Journal of clinical pharmacy and therapeutics.

[20]  J. Kai,et al.  Health Care Needs Assessment: Black and Minority Ethnic Groups , 2005 .

[21]  Brad Pascal Blanchard.  Concordance: A Partnership in Medicine-Taking , 2005 .

[22]  G. Elwyn,et al.  BMC Family Practice , 2005 .

[23]  P. Gill,et al.  Prescribing patterns in high‐need Health Authority populations: how does an ethnically mixed composition affect volume and cost? , 2004, Journal of clinical pharmacy and therapeutics.

[24]  Peter Littlejohns,et al.  NICE clinical guidelines: Maybe health economists should participate in guideline development , 2004, BMJ : British Medical Journal.

[25]  P. Gill,et al.  The use of lipid-lowering drugs across ethnic groups in the secondary prevention of ischaemic heart disease: analysis of cross-sectional surveys in England. , 2004, The British journal of general practice : the journal of the Royal College of General Practitioners.

[26]  D. Lewis,et al.  Who decides when to start preventive treatment? A questionnaire survey to compare the views of different population subgroups , 2003, Journal of epidemiology and community health.

[27]  R. Thomson,et al.  Decision aids for people facing health treatment or screening decisions. , 2003, The Cochrane database of systematic reviews.

[28]  G. Brennan,et al.  Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs. , 2002, Clinical medicine.

[29]  G. Tyerman,et al.  Primary prevention strategies for cardiovascular disease , 2002, BMJ : British Medical Journal.

[30]  T. Marshall,et al.  Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study , 2002, BMJ : British Medical Journal.

[31]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[32]  P. Gill,et al.  Prescribing of lipid lowering drugs to South Asian patients: ecological study , 2002, BMJ : British Medical Journal.

[33]  G. Elwyn,et al.  One hundred years ago: Should milk be boiled? , 2002, BMJ : British Medical Journal.

[34]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[35]  P Kinnersley,et al.  Shared decision making and the concept of equipoise: the competences of involving patients in healthcare choices. , 2000, The British journal of general practice : the journal of the Royal College of General Practitioners.

[36]  N. Steel,et al.  Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey , 2000, BMJ : British Medical Journal.

[37]  C P Bradley,et al.  Doctor-patient communication about drugs: the evidence for shared decision making. , 2000, Social science & medicine.

[38]  N. Britten,et al.  Misunderstandings in general practice prescribing decisions: a qualitative study , 2000 .

[39]  C P Bradley,et al.  Misunderstandings in prescribing decisions in general practice: qualitative study , 2000, BMJ : British Medical Journal.

[40]  S. Ebrahim,et al.  Multiple risk factor interventions for primary prevention of coronary heart disease. , 2000, The Cochrane database of systematic reviews.

[41]  W Godolphin,et al.  Framework for teaching and learning informed shared decision making. , 1999, BMJ.

[42]  G. Elwyn,et al.  Shared decision-making in primary care: the neglected second half of the consultation. , 1999, The British journal of general practice : the journal of the Royal College of General Practitioners.

[43]  C. Hogg.  Patients, Power and Politics: From Patients to Citizens , 1999 .

[44]  Petros Nihoyannopoulos,et al.  Joint British recommendations on prevention of coronary heart disease in clinical practice , 1998, Heart.

[45]  A. Laupacis,et al.  A survey of clinician attitudes and management practices in hypertension , 1997, Journal of Human Hypertension.

[46]  C. Charles,et al.  Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). , 1997, Social science & medicine.

[47]  T. Walley,et al.  Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. , 1996, The British journal of general practice : the journal of the Royal College of General Practitioners.

[48]  K. A. McKibbon,et al.  Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications , 1996, The Lancet.

[49]  N. Britten.  Patients' ideas about medicines: a qualitative study in a general practice population. , 1994, The British journal of general practice : the journal of the Royal College of General Practitioners.

[50]  B. Demichelis,et al.  Completeness of reporting trial results: effect on physicians' willingness to prescribe , 1994, The Lancet.

[51]  C D Naylor,et al.  Measured Enthusiasm: Does the Method of Reporting Trial Results Alter Perceptions of Therapeutic Effectiveness? , 1992, Annals of Internal Medicine.

[52]  L. Payer.  Disease-Mongers: How Doctors, Drug Companies, and Insurers Are Making You Feel Sick , 1992 .

[53]  J. Holmen,et al.  [The diagnosis of hypertension--psychosocial consequences. A literature review of blood pressure examinations]. , 1992, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[54]  G. Smith,et al.  Lay epidemiology and the prevention paradox: the implications of coronary candidacy for health education , 1991 .

[55]  D. Sackett,et al.  Labelling in hypertension: a review of the behavioural and psychological consequences. , 1984, Journal of chronic diseases.

[56]  W. Katon,et al.  Doctor-Patient Negotiation and Other Social Science Strategies in Patient Care , 1981 .